Karla Lingard

782 total citations
2 papers, 60 citations indexed

About

Karla Lingard is a scholar working on Molecular Biology, Oncology and Economics and Econometrics. According to data from OpenAlex, Karla Lingard has authored 2 papers receiving a total of 60 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Economics and Econometrics. Recurrent topics in Karla Lingard's work include Cancer Immunotherapy and Biomarkers (2 papers), Melanoma and MAPK Pathways (2 papers) and CAR-T cell therapy research (1 paper). Karla Lingard is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Melanoma and MAPK Pathways (2 papers) and CAR-T cell therapy research (1 paper). Karla Lingard collaborates with scholars based in United Kingdom and United States. Karla Lingard's co-authors include Natalie Pattison, Lewis Au, Samra Turajlic, Joanna Lynch, Aine O’Reilly, Kim Edmonds, Olga Husson, Theresa Wiseman, Martin Gore and Jhia Jiat Teh and has published in prestigious journals such as Supportive Care in Cancer and Journal of the Advanced Practitioner in Oncology.

In The Last Decade

Karla Lingard

2 papers receiving 59 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karla Lingard United Kingdom	2	51	14	9	7	5	2	60
Joanna Lynch United Kingdom	2	61 1.2×	18 1.3×	9 1.0×	7 1.0×	3 0.6×	4	85
Blanca Ledezma United States	5	49 1.0×	17 1.2×	7 0.8×	3 0.4×	8 1.6×	11	52
Fanny Pommeret France	3	41 0.8×	5 0.4×	7 0.8×	8 1.1×	4 0.8×	18	60
Ewa Szutowicz-Zielińska Poland	3	23 0.5×	17 1.2×	9 1.0×	3 0.4×	8 1.6×	5	39
F. Marmé Germany	3	46 0.9×	12 0.9×	8 0.9×	10 1.4×	2 0.4×	4	58
Ricarda Rauschenberg Germany	6	44 0.9×	19 1.4×	33 3.7×	3 0.4×	4 0.8×	10	83
Hana Zahed France	5	41 0.8×	15 1.1×	15 1.7×	6 0.9×	6 1.2×	10	81
Amelie Franken Belgium	3	39 0.8×	23 1.6×	9 1.0×	2 0.3×	4 0.8×	7	52
Nira A. Krasnow United States	4	53 1.0×	8 0.6×	9 1.0×	1 0.1×	6 1.2×	6	62
Meredith Faggen United States	5	34 0.7×	10 0.7×	3 0.3×	2 0.3×	4 0.8×	11	48

Countries citing papers authored by Karla Lingard

Since Specialization

Citations

This map shows the geographic impact of Karla Lingard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karla Lingard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karla Lingard more than expected).

Fields of papers citing papers by Karla Lingard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karla Lingard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karla Lingard. The network helps show where Karla Lingard may publish in the future.

Co-authorship network of co-authors of Karla Lingard

This figure shows the co-authorship network connecting the top 25 collaborators of Karla Lingard. A scholar is included among the top collaborators of Karla Lingard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karla Lingard. Karla Lingard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

2 of 2 papers shown

1.

O’Reilly, Aine, Jhia Jiat Teh, Emma McLean, et al.. (2019). An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors. Supportive Care in Cancer. 28(2). 561–570. 52 indexed citations

2.

Kasler, Mary Kate, et al.. (2017). Understanding and Managing Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Advanced Melanoma. Journal of the Advanced Practitioner in Oncology. 8(1). 58–72. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact